BioSpace News Archive

Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, announced that it is leading a consortium that has been awarded a €4 million grant from Horizon Europe, the European Union’s key funding program for research and innovation.

Addex Therapeutics Ltd announced the reduction of the nominal value of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01, following the expiration of a period of two months after the third creditor call in The Swiss Gazette of Commerce in accordance with article 732 of Swiss Code of Obligations.

Sartorius Stedim Biotech, a leading partner of the biopharma industry, increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.

RELIEF THERAPEUTICS Holding SA announced that the U.S. Securities and Exchange Commission has declared effective its Registration Statement on Form 20-F.

The global Cri-du-chat syndrome treatment market is projected to expand at a favorable rate from 2021 to 2031.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The products and solutions offered by the manufacturers and players functional within the global blood transfusion devices market are used by various end users in the healthcare and medical industries, such as hospitals, blood banks, and ambulatory surgical centers, among others.

The global veterinary stereotactic radiosurgery system market is expected to witness moderate growth during the forecast period between 2021 and 2031.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global zein protein market stood at US$ 2.17 Billion in 2022 and is expected to reach US$ 3.76 Bn by the end of 2032.

Wilmington, Delaware, United States, Transparency Market Research Inc.: DNA sequencing is expected to show a promising growth during the forecast period of 2021-2031 due to its execution in various applications such as microarray and other analysis methods.

Danaher Corporation announced results for the second quarter 2022. All results in this release reflect only continuing operations unless otherwise noted.